1. OECD. High level forum on medicines for neglected and emerging infectious diseases: policy coherence to enhance their availability. Noordwijk-Aan-Zee, The Netherlands, June 20–21, 2007. http://www.oecd.org/document/31/0,3343,en_2649_18532957_38202975_1_1_1_1,00.html [accessed August 10, 2007].
2. Developing Country Vaccine Manufacturers Network (DCVMN), April 26–27, 2001, Bandung, Indonesia;Poeloengan;Vaccine,2001
3. Developing Country Vaccine Manufacturers Network (DCVMN). Website: http://www.dcvmn.com/ [accessed August 10, 2007].
4. A systematic method for evaluating the potential viability of local vaccine producers;Milstien;Vaccine,1997
5. Kreeftenberg JG, Hamidi A. Annex 5. Lessons learned in the transfer of Hib conjugate vaccine technology and the consequences for access to this vaccine in developing countries. In: WHO Meeting Report. Intellectual Property Rights and Vaccines in Developing Countries, April 19–20, 2004. WHO Document WHO/IVB/04.21. http://www.who.int/vaccines-documents/DocsPDF05/Dip-789-screen.pdf [accessed August 16, 2007].